HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ZEPP

Zepp Health Corporation (NYSE)

Technology — Consumer Electronics

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is based in Gorinchem, The Netherlands.

None 1 analysts
$5.20
+$0.02 (+0.39%)
Target: $56.28 (982.3%)
Sign in to add ZEPP to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$76.26M
P/E Ratio (TTM)-
Forward P/E74.29
EPS (TTM)$-2.56
Dividend Yield-
Profit Margin-14.70%
Revenue Growth33.80%
ROE-18.76%
Debt/Equity66.09
Recommendation None
Analyst Target$56.28
Analysts1
Indexes NYSE

Technical Indicators

RSI (14)56.7
Beta1.78
SMA 20-
SMA 40-
52-Week High$61.85
52-Week Low$2.86
50-Day Avg$9.64
200-Day Avg$23.78
Avg Volume134.5K
Volume604

Performance Analysis

BULLISH

ZEPP shows predominantly bullish signals based on its fundamentals and technicals.

+ Trading near its 52-week low ($2.86), which could present a value opportunity.
+ RSI at 56.7 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ Strong revenue growth of 33.8% year-over-year.
- Operating at a loss with -14.7% margin.
~ Wall Street consensus is "none" from 1 analysts.
+ Average analyst target of $56.28 implies 982.3% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:39 UTC

Back to Screener Export Report